Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19082046 | 0.92 | ALOX5 (0.38) | ALOX5CYP1A2AHRTDP1L3MBTL1 | |
| SCHEMBL19081865 | 0.87 | ABCG2 (0.34) | ALOX5CYP1A1CYP1A2FYNMAPK3 | |
| SCHEMBL19081974 | 0.86 | NPC1 (0.34) | ALOX5CYP1A1CYP1A2FYNMAPK3 | |
| SCHEMBL19081814 | 0.84 | NPC1 (0.34) | ALOX5CYP1A1CYP1A2FYNMAPK3 | |
| SCHEMBL19081560 | 0.84 | AHR (0.38) | ALOX5CYP1A1CYP1A2FYNMAPK3 | |
| SCHEMBL10122365 | 0.83 | ALOX5 (0.42) | ALOX5CYP1A2AHRTDP1L3MBTL1 | |
| SCHEMBL19082276 | 0.83 | ALOX5 (0.36) | ALOX5CYP1A1L3MBTL1 | |
| SCHEMBL19076883 | 0.82 | ALOX5 (0.35) | ALOX5 | |
| SCHEMBL19081806 | 0.82 | TDP1 (0.36) | ALOX5CYP1A2AHRTDP1L3MBTL1 | |
| SCHEMBL19081940 | 0.82 | TDP1 (0.33) | ALOX5TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170194572-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
| US-20170194572-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170194572-A1 | CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNT1 | ALOX5 1939/4885CYP1A1 184/4885CYP1A2 659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.